Clinical Trial Update: A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence [Phase 2]

View source ↗

Summary

Phase 2 trial update for TAS-303 in female patients with stress urinary incontinence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• TAS-303

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Stress Urinary Incontinence | Phase 2 | Status: COMPLETED